The Joint Committee on Vaccination and Immunisation (JCVI) has advised that people aged 12 and over with severely weakened immune systems should have a third vaccine dose as part of their primary COVID-19 Vaccination schedule.

Who will this cover?

It will include people who were severely immunosuppressed at the time of their first or second dose, including those with leukaemia, advanced HIV and recent organ transplants.

Why is the third dose being being offered?

This advice follows clinical evidence that these people may not have a full response to vaccination and therefore may be less protected than the wider population.

How will people find out about it?

The NHS will contact people as soon as possible to discuss their needs and arrange an appointment for a third dose where clinically appropriate.
This offer is separate to any booster programme. In the event of a booster programme, it is expected that severely immunosuppressed people will also be offered a booster dose, at a suitable interval after their third dose.

What's the difference between a third dose and a booster?

The third primary dose is an extra ‘top-up’ dose for those who may not have generated a full immune response to the first two doses. In contrast, a booster dose is a later dose to extend the duration of protection from the primary course of vaccinations.

© Healthwatch Derbyshire 2022

WordPress website built by Jason King